Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera

Journal of Immunological Methods
Ilaria CavazzanaFranco Franceschini

Abstract

To analyze the performance of a line blot assay for the identification of autoantibodies in sera of patients affected by myositis, compared with immunoprecipitation (IP) as gold standard. 66 sera of patients with myositis (23 polymyositis, 8 anti-synthetase syndromes, 29 dermatomyositis and 6 overlap syndromes) were tested by commercial LB (Euroimmun, Lubeck, Germany); 57 sera were analyzed also by IP of K562 cell extract radiolabeled with (35)S-methionine. Inter-rater agreement was calculated with Cohen's k coefficient. Myositis-specific antibodies (MSA) were detected in 36/57 sera (63%) by IP and in 39/66 sera (59%) by LB. The most frequent MSA found by LB were anti-Jo1 and anti-Mi2 found in 15% (10/66) of sera, followed by anti-NXP2 and anti-SRP detected in 106% (7/66) of sera. Anti-TIF1gamma and anti-MDA5 were found in 6 (9%) and 5 sera (7.6%), respectively. A good agreement between methods was found only for anti-TIF1γ, anti-MDA5 and anti-NXP-2 antibodies, while a moderate agreement was estimated for anti-Mi2 and anti-EJ. By contrast, a high discordance rate for the detection of anti-Jo1 antibodies was evident (k: 0.3). Multiple positivity for MSA were found in 11/66 (17%) by LB and 0/57 by IP (p: 0001). Comparing the clin...Continue Reading

References

Oct 1, 1982·Annals of the Rheumatic Diseases·R M BernsteinG R Hughes
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Nov 25, 2000·Current Opinion in Rheumatology·I N Targoff
Jun 20, 2003·Joint, Bone, Spine : Revue Du Rhumatisme·Agathe Imbert-MasseauPascal Chérin
May 3, 2011·Journal of the American Academy of Dermatology·David FiorentinoLivia Casciola-Rosen
Feb 26, 2013·Arthritis Care & Research·John C HallLisa Christopher-Stine
Sep 21, 2013·Current Opinion in Rheumatology·Sarah L TansleyNeil J McHugh

❮ Previous
Next ❯

Citations

Aug 19, 2016·Current Opinion in Neurology·Olivier BenvenisteYves Allenbach
Nov 18, 2017·Virchows Archiv : an International Journal of Pathology·Bruna CerbelliCarla Giordano
Apr 21, 2018·Nature Reviews. Rheumatology·Neil J McHugh, Sarah L Tansley
Jul 25, 2018·Journal of Cutaneous Pathology·Aadil AhmedWilma Bergfeld
Oct 13, 2017·Clinical and Vaccine Immunology : CVI·Anne E Tebo
Aug 4, 2018·Current Opinion in Rheumatology·Micaela FrediFranco Franceschini
Mar 3, 2018·The Journal of Rheumatology·Marvin J FritzlerMichael Mahler
Mar 16, 2018·Clinical and Molecular Allergy : CMA·Boaz PaltererPaola Parronchi
Mar 15, 2018·Annals of the Rheumatic Diseases·Maria InfantinoMaurizio Benucci
Feb 16, 2018·Annals of the Rheumatic Diseases·Michael Mahler, Marvin J Fritzler
Mar 4, 2019·Practical Neurology·Anke RietveldChristiaan Saris
Nov 23, 2019·Journal of Clinical Medicine·Lorenzo CavagnaMiguel Angel Gonzalez-Gay
Oct 23, 2018·Neurology. Neuroimmunology and Neuroinflammation·Johan LimMarianne de Visser
Aug 18, 2016·Current Opinion in Rheumatology·Sarah L Tansley
Aug 8, 2020·Acta Neurologica Scandinavica·Victor Tak-Lung WongRonald Man-Lung Yip
Sep 6, 2020·Current Opinion in Rheumatology·Victoria RiddellNeil McHugh
Apr 3, 2019·Immunological Medicine·Ran Nakashima
Mar 20, 2018·Current Rheumatology Reports·Valérie Leclair, Ingrid E Lundberg
May 23, 2019·Frontiers in Immunology·Michael MahlerNeil McHugh
Jul 17, 2019·Annals of the Rheumatic Diseases·Ilaria CavazzanaFranco Franceschini
Jan 7, 2021·Clinical Reviews in Allergy & Immunology·Wanlong WuShuang Ye
Nov 7, 2020·Nature Reviews. Rheumatology·Xavier BossuytPier Luigi Meroni
Dec 22, 2020·Therapeutic Advances in Musculoskeletal Disease·Angelika LacknerMartin H Stradner
Feb 23, 2021·Frontiers in Immunology·Anaís MariscalAlbert Selva-O'Callaghan
Feb 26, 2021·Clinical Rheumatology·Mithu MaheswaranathanLisa Criscione-Schreiber
Feb 4, 2019·Joint, Bone, Spine : Revue Du Rhumatisme·Alain Meyer, Jean Sibilia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.